BRISTOL MYERS SQUIBB CO
BMY
35 insider filings · Latest: May 1, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Apr 1, 2026 | Apr 2 8:29 PM | David V ElkinsEVP, Chief Financial Officer | Sale | 30,000 | $61.67 | $1.9M | 159,248(D) | View → |
| Apr 1, 2026 | Apr 1 8:32 PM | Elkins David V | Proposed Sale | 30,000 | $61.69 | $1.9M | — | View → |
| Sep 2, 2025 | Sep 2 3:16 PM | Elkins David V | Proposed Sale | 56,000 | $47.30 | $2.6M | — | View → |
| Nov 4, 2024 | Nov 4 4:20 PM | Holzer Phil M | Proposed Sale | 700 | $55.62 | $38.9K | — | View → |
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Mar 10, 2026 | Mar 12 8:17 PM | Phil M HolzerSVP and Controller | Grant/Award | 12,578 | — | 7,547(D) | View → |
| Mar 10, 2026 | Mar 12 8:17 PM | Phil M HolzerSVP and Controller | Option Exercise | 6,191 | — | 0(D) | View → |
| Mar 10, 2026 | Mar 12 8:17 PM | Lynelle HochPresident, Cell Therapy Org. | Option Exercise | 8,192 | — | 0(D) | View → |
| Mar 10, 2026 | Mar 12 8:17 PM | Lynelle HochPresident, Cell Therapy Org. | Grant/Award | 16,327 | — | 9,796(D) | View → |
| Mar 10, 2026 | Mar 12 8:16 PM | Cari GallmanEVP, General Counsel | Option Exercise | 6,980 | — | 0(D) | View → |
| Mar 10, 2026 | Mar 12 8:16 PM | Cari GallmanEVP, General Counsel | Grant/Award | 65,306 | — | 39,184(D) | View → |
| Mar 10, 2026 | Mar 12 8:15 PM | Ahn Amanda PooleEVP, Chief People Officer | Option Exercise | 6,436 | — | 0(D) | View → |
| Mar 10, 2026 | Mar 12 8:15 PM | Ahn Amanda PooleEVP, Chief People Officer | Grant/Award | 38,367 | — | 23,020(D) | View → |
| Mar 10, 2026 | Mar 12 8:14 PM | Christopher S. BoernerDirector, Chief Executive Officer | Option Exercise | 71,537 | — | 0(D) | View → |
| Mar 10, 2026 | Mar 12 8:14 PM | Christopher S. BoernerDirector, Chief Executive Officer | Grant/Award | 261,225 | — | 156,735(D) | View → |
| Mar 10, 2026 | Mar 12 8:13 PM | David V ElkinsEVP, Chief Financial Officer | Option Exercise | 62,982 | — | 0(D) | View → |
| Mar 10, 2026 | Mar 12 8:13 PM | David V ElkinsEVP, Chief Financial Officer | Grant/Award | 88,163 | — | 52,898(D) | View → |
| Feb 27, 2026 | Mar 3 9:16 PM | Benjamin HickeyPresident, RayzeBio Org. | Option Exercise | 3,286 | — | 3,286(D) | View → |
| Feb 1, 2026 | Feb 3 9:40 PM | Gregory Scott MeyersEVP, Chief Digital & Tech Off. | Option Exercise | 2,543 | — | 0(D) | View → |
| Feb 1, 2026 | Feb 3 9:39 PM | Benjamin HickeyPresident, RayzeBio Org. | Option Exercise | 10,079 | — | 10,079(D) | View → |
| Feb 1, 2026 | Feb 3 9:36 PM | Phyllis R YaleDirector | Grant/Award | 3,996.367 | — | 43,326.695(D) | View → |
| Feb 1, 2026 | Feb 3 9:35 PM | Karen H VousdenDirector | Grant/Award | 3,996.367 | — | 41,069.315(D) | View → |
| Feb 1, 2026 | Feb 3 9:34 PM | Theodore R. Samuels IIDirector | Grant/Award | 3,996.367 | — | 67,882.504(D) | View → |
| Feb 1, 2026 | Feb 3 9:30 PM | Derica W RiceDirector | Grant/Award | 3,996.367 | — | 39,324.809(D) | View → |
| Feb 1, 2026 | Feb 3 9:29 PM | Paula A PriceDirector | Grant/Award | 3,996.367 | — | 25,498.163(D) | View → |